Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SHE:301211)
China · Delayed Price · Currency is CNY 10.94
+0.19 (1.77%)
Oct 23, 2026, 3:04 PM CST
SHE:301211 Market Cap
SHE:301211 has a market cap or net worth of 4.57 billion as of October 23, 2026. It is the 12,677th most valuable company in the world and the 3,160th biggest in China. Its market cap has decreased by 27.02% in one year.
Market Cap
4.57B
Enterprise Value
3.03B
Revenue
466.05M
Global Rank
Country Rank
#3,160 China
PE Ratio
98.77
ChartMarket Cap Chart
Since December 22, 2021, SHE:301211's market cap has decreased from 8.96B to 4.57B, a decrease of -48.99%. That is a compound annual growth rate of -12.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 4.57B | -10.47% |
| Dec 31, 2025 | 5.10B | -16.66% |
| Dec 31, 2024 | 6.12B | -2.25% |
| Dec 29, 2023 | 6.26B | -24.68% |
| Dec 30, 2022 | 8.32B | -7.87% |
| Dec 31, 2021 | 9.03B | 0.78% |
| Dec 22, 2021 | 8.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding